Viewing Study NCT05609903


Ignite Creation Date: 2025-12-24 @ 7:15 PM
Ignite Modification Date: 2026-01-26 @ 8:15 AM
Study NCT ID: NCT05609903
Status: COMPLETED
Last Update Posted: 2022-11-08
First Post: 2022-11-02
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Atezolizumab With Nab-paclitaxel for Patients With Triple-negative Stage IV Breast Cancer
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer Metastatic View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Atezolizumab; Nab-Paclitaxel, Metastatic Breast Cancer; View